Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2025 R&D 100 Award Winners
    • 2025 Professional Award Winners
    • 2025 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Organic Nanoparticles Are Better at Fighting Tumors

By R&D Editors | May 19, 2015

Radiotherapy used in cancer treatment is a promising treatment method, albeit rather indiscriminate. Indeed, it affects neighboring healthy tissues and tumors alike. Researchers have thus been exploring the possibilities of using various radio-sensitizers; these nanoscale entities focus the destructive effects of radiotherapy more specifically on tumor cells. In a study published in EPJ D, physicists have now shown that the production of low-energy electrons by radio-sensitizers made of carbon nanostructures hinges on a key physical mechanism referred to as plasmons – collective excitations of so-called valence electrons; a phenomenon already documented in rare metal sensitizers. This research was conducted by Alexey Verkhovtsev, affiliated with the MBN Research Center in Frankfurt, Germany and A.F. Ioffe Physical-Technical Institute in St Petersburg, Russia and an international team.

Nanoparticle radio-sensitizers are nanoscale compounds, typically composed of rare metals such as coated gold, platinum, or gadolinium. Alternatives sensitizers could be made of carbon-based nanostructures, such as fullerenes or nanotubes, provided they are biocompatible and non-toxic. Previous studies have revealed that gold and platinum nanoparticles produce a large number of electrons via the plasmon excitation mechanism. In the case of a carbon nanoparticle, this phenomenon yields electrons with higher energy than pure metals, thus inducing greater biological damage.

In this study, the authors analyzed the spectra of secondary electrons emitted from a carbon nanoparticle composed of fullerite, a crystalline form of C60 fullerene, irradiated by an ion beam consisting of fast protons. They quantified the electron yield in a broad kinetic energy range, using several different theoretical and numerical approaches. They found that a medium with an embedded carbon nanoparticle results in a number of low-energy electrons several times higher than that emitted by pure water. This may lead to the development of novel types of sensitizers composed of metallic and carbon-based parts.

Release Date: May 17, 2015
Source: Springer 

Related Articles Read More >

Interactive Data Analysis and Forecasting. Business and finance concept.
The future of science: 15 big predictions for 2026 in tech, AI and biopharma
RED-CRISPR doubles knock-in efficiency
Thermo Fisher adds chemically defined E. coli fermentation medium and feed to Gibco Bacto line
JLL: 2026 could be a realignment year for life science labs
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2025 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

R&D 100 Awards
Research & Development World
  • Subscribe to R&D World Magazine
  • Sign up for R&D World’s newsletter
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2025 R&D 100 Award Winners
    • 2025 Professional Award Winners
    • 2025 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE